RxDoctor Payments Data

H Robert Gaetano

Optometrist · Youngstown, OHNPI 1235135807

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Alcon accounts for 84.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $27,526 and has fallen 99.1% since, to $237 in 2025. Among optometrist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$47,956in general payments, 2019–2025

Across 187 payments — averaging $256.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$41K
  • Alcon Research LLC$4K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
  • Coopervision Inc.$618
  • ABB Con-cise Optical Group LLC$96
  • Carl Zeiss Meditec, Inc.$52
  • plus $81 from 4 others

What the payments were for

  • Consulting fees$25,36553%
  • Travel & lodging$18,33938%
  • Food & beverage$4,2329%
  • Gifts$190%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,956 in reported general payments places this provider in the 95th percentile of 1,995 optometrist providers in Ohio.

See all optometrist providers in Ohio

Medicare billing

Part B allowed, 2024
$43,142
Medicare patients
282
Services billed
3,218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine22$16,341
Timolol Maleate20$2,259
Latanoprost203$2,187
Tobramycin-DexamethasoneTobramycin/Dexamethasone55$1,525
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha88$1,022
Prednisolone Acetate14$480
Brimonidine Tartrate11$14

Paid to pharmacies, not to this prescriber.

Other optometrist in Youngstown

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →